Berlin's Kyrok Secures €3.1 Million Pre-Seed Funding
Kyrok, a Berlin-based startup, has successfully raised €3.1 million in a pre-seed funding round. This financial boost is led by Speedinvest, with additional participation from Arve Capital. Founded in 2025 by Daniel Hofinger and Lukas Bierfreund, Kyrok is developing an AI operating system tailored for mid-sized pharmaceutical and chemical companies. This system aims to streamline supply chain management by integrating with existing ERP systems and enhancing operations through AI-driven processes.
Transforming Industrial Supply Chains
Kyrok's platform is designed to overlay existing ERP systems, connecting fragmented workflows across various departments such as customer service, production planning, material planning, and procurement. By employing AI agents to handle routine tasks like order processing and data management, the platform reduces manual workload and enhances accuracy. Employees remain in charge of final decisions, ensuring that operational expertise is retained within the organization.
The platform also captures operational knowledge that is traditionally scattered across spreadsheets and relies on individual experience. This is particularly beneficial for industries with aging workforces and outdated software, as it reduces dependency on specific employees and modernizes operations without disrupting them.
Use of Funds
The newly acquired funds will be directed towards further development of Kyrok's platform, particularly in expanding its supply chain modules beyond customer service. The company plans to scale its product across more small and medium-sized enterprises (SMEs) in the pharmaceutical and chemical sectors. Additionally, Kyrok intends to grow its team based in Berlin to support these expansions.
Investor Insights
Florian Obst, a partner at Speedinvest, commented on the investment: "Daniel and Lukas have already shown that they can make industrial companies more competitive through technology. With Kyrok, they are modernizing an entire sector without taking it offline to do it. That is exactly the kind of leverage Europe needs to keep its SMEs competitive and its pharma and chemical supply chains resilient."
Future Outlook
Kyrok's innovative approach to supply chain management positions it well within an industry that is increasingly looking for technological solutions to improve efficiency and resilience. With the backing of investors like Speedinvest and Arve Capital, the company is poised to make significant strides in enhancing the operational capabilities of mid-sized pharmaceutical and chemical firms. As Kyrok continues to develop and expand its offerings, it will be interesting to observe how its platform impacts the broader landscape of industrial supply chains.